X
Xiubo Jiang
Researcher at Nanjing Tech University
Publications - 5
Citations - 211
Xiubo Jiang is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Apoptosis & Akt/PKB signaling pathway. The author has an hindex of 5, co-authored 5 publications receiving 116 citations.
Papers
More filters
Journal ArticleDOI
Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway
TL;DR: Oridonin exerted a dramatic pro-apoptotic effect by activating PPAR-γ and inhibiting Nrf2 pathway in vitro and in vivo, and may be a promising and effective agent for human osteosarcoma in the future clinical applications.
Journal ArticleDOI
Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1.
Runyu Yang,Changqin Song,Jiaxi Chen,Lvqi Zhou,Xiubo Jiang,Xiaomei Cao,Yang Sun,Yang Sun,Qi Zhang,Qi Zhang +9 more
TL;DR: Limonin mitigated APAP-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1, and demonstrated that limonin had therapeutic promise in AP AP-induced liver injury.
Journal ArticleDOI
Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma
TL;DR: It is demonstrated that Glaucocalyxin A inhibited EMT and TGF-β1-induced EMT by inhibiting TGF -β1/Smad2/3 signaling pathway in osteosarcoma.
Journal ArticleDOI
Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway.
TL;DR: It is suggested that Glaucocalyxin A induced apoptosis in osteosarcoma by inhibiting nuclear translocation of GLI1 via regulating PI3K/Akt signaling pathway, which might be a potential candidate for human osteosARcoma in the future.
Journal ArticleDOI
Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
TL;DR: Investigating the underlying mechanism of oridonin on EMT and metastasis of osteosarcoma found that oridon in inhibited migration and invasion of MG-63 and 143B cells and increased the protein expression of E-cadherin and decreased that of N- cadher in and Vimentin.